U.S. Physical Therapy, Inc. (NYSE:USPH) COO Graham D. Reeve Sells 1,792 Shares

Key Points

• U.S. Physical Therapy COO Graham D. Reeve sold 1,792 shares at an average price of $86.57, reducing his holdings by 7.45% to a total of 22,246 shares worth approximately $1.93 million.
• The company reported a net margin of 5.05% and revenue of $197.34 million for the last quarter, exceeding estimates and showing an 18.0% increase compared to the previous year.
• U.S. Physical Therapy declared a quarterly dividend of $0.45 per share, with an annual yield of 2.1%, to be paid on September 12th.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) COO Graham D. Reeve sold 1,792 shares of the business's stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $86.57, for a total transaction of $155,133.44. Following the sale, the chief operating officer owned 22,246 shares in the company, valued at $1,925,836.22. This represents a 7.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

U.S. Physical Therapy Stock Up 0.6%

USPH stock traded up $0.55 during trading hours on Tuesday, hitting $87.26. The company's stock had a trading volume of 207,943 shares, compared to its average volume of 196,449. The company has a quick ratio of 1.17, a current ratio of 1.18 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $1.33 billion, a PE ratio of 38.10, a price-to-earnings-growth ratio of 4.36 and a beta of 1.45. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $101.19. The stock has a 50 day moving average price of $76.91 and a two-hundred day moving average price of $77.02.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.71 by $0.10. The company had revenue of $197.34 million during the quarter, compared to the consensus estimate of $190.24 million. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The company's revenue for the quarter was up 18.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.73 earnings per share. On average, equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Friday, August 22nd. U.S. Physical Therapy's dividend payout ratio is currently 78.60%.

Wall Street Analysts Forecast Growth

USPH has been the topic of a number of research analyst reports. JMP Securities reaffirmed a "market outperform" rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Barrington Research boosted their price objective on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the company an "outperform" rating in a research report on Friday. Finally, Wall Street Zen raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, U.S. Physical Therapy currently has an average rating of "Moderate Buy" and a consensus target price of $110.25.

Institutional Trading of U.S. Physical Therapy

Large investors have recently modified their holdings of the company. GAMMA Investing LLC boosted its holdings in shares of U.S. Physical Therapy by 27,856.8% during the 1st quarter. GAMMA Investing LLC now owns 12,301 shares of the company's stock worth $890,000 after buying an additional 12,257 shares during the period. Lazard Asset Management LLC bought a new stake in shares of U.S. Physical Therapy during the 4th quarter worth $84,000. Wells Fargo & Company MN raised its stake in U.S. Physical Therapy by 2.2% during the 4th quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock valued at $10,021,000 after purchasing an additional 2,465 shares during the last quarter. Deutsche Bank AG raised its stake in U.S. Physical Therapy by 49.3% during the 4th quarter. Deutsche Bank AG now owns 13,176 shares of the company's stock valued at $1,169,000 after purchasing an additional 4,350 shares during the last quarter. Finally, Principal Financial Group Inc. raised its stake in U.S. Physical Therapy by 2.3% during the 1st quarter. Principal Financial Group Inc. now owns 84,964 shares of the company's stock valued at $6,148,000 after purchasing an additional 1,873 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.